Abstract
Results

RNA editing sites consistently edited in human blood samples
Of the ~ 2M editing sites reported in RADAR database, our dataset of 459 RNA-seq samples had adequate coverage for 709,184 sites, covering > 75% of the total sites reported for genes expressed in blood according to GTEx data. (Additional file 1: Figure S1 ). Most of these sites are edited only in a small fraction of samples and 691,304 (97.5%) have no detectable editing levels in our cohort (Additional file 1: Figure S2 ). To provide a picture of the most biologically relevant editing sites in human blood we focalized our attention on 2,079 consistently editing sites (CES), namely those with at least 5% of editing level in at least 20% of individuals. These sites are mainly distributed in ALU regions (1, 805 ; 86.5%) and 3'UTR regions (1,234; 59.4%), distributed across 421 genes.
Overall, we detected 1,266 sites in exons of protein coding genes, including 10 recoding sites (resulting in a missense substitution) and 12 synonymous sites. We also detected 53 sites annotated on ncRNAs (Figure 1a, b) . Detailed statistics of the 2,079 trusted sites are reported in Additional file 2, while recoding sites in Table 1 .
Considering mean values for each site, detected editing levels range from 0.05 to 1, with most sites showing moderate editing levels between 0.05 and 0.30 ( Figure 1c ). We also detected 33 sites highly edited (mean value ≥ 0.9), located mainly in intronic regions (Figure 1d ). Highly edited sites are reported in Additional file 1: Table S1 . To further assess reliability of detected sites, we compared the CES editing levels with those reported in the REDIportal database [26] , a wellestablished resources containing multi-tissue estimations of RNA editing levels. The comparison revealed high concordance (concordance correlation coefficient 0.84, Additional file 1: Figure S3 ), for 2,035 and 2,003 sites when considering the whole REDIportal dataset or blood tissue data, respectively. For the sites included in this study, the editing levels from REDIportal are reported in Additional file 2.
We used Spearman correlation test to analyze correlation in editing level changes across the 2,079 CES to find sites with co-regulated RNA editing. We found 540 significant relationships (FDR < 0.05) involving 361 sites. Correlations were generally low with only 58 sites with relationships above 0.5 rho value. Correlations become stronger for close sites, especially below 50 bp distance, with 60 out of 66 (91%) high rho (≥ 0.5) relationships located in this range. No strong negative correlations (rho < -0.5) were observed (Additional file 1: Figure S4 ).
Genes influencing the total editing rate of CES
We performed regression analysis to identify genes whose expression is associated to the CES total editing rate, calculated for each subject as the total sum of G-containing reads divided by the total number of reads observed at all the 2,079 CES. The analysis revealed 4,719 genes associated to the CES total editing rate (FDR < 0.05). Enrichment analysis on Gene Ontology biological processes (GO-BP) revealed a strong enrichment for genes involved in immune system and interferon signaling (FDR < 1e-6, Figure 2a ). Among significant genes, ADAR emerged as the top influencing factor, explaining about 13% of the observed variability, while ADARB1 showed no significant effect ( Figure 2b ). The influence of ADAR was similar on ALU (~10%) and non-ALU (~13%) sites, while ADARB1 remains not associated also when considering groups separately (Additional file 1: Figure S5 ). ADARB2 gene was not detectable in our gene expression data. When the same analysis was repeated removing ADAR effect, we obtained 1,122 genes associated to CES total editing rate (FDR < 0.05), including 376 with a strong association at FDR < 0.01 (Additional file 3).
Enrichment analysis on GO-BP and REACTOME pathways revealed that these genes mainly impact ribonucleoprotein complex biogenesis and RNA metabolism / processing (Figure 2c ).
To assess possible interactions between ADAR enzymes and genes whose expression is associated with CES total editing rate, we performed network analysis using data on protein-protein interactions from STRING v.10, BioPlex and BIOGRID databases. We created a 415 proteins network including genes significantly associated with CES total editing rate (FDR < 0.01) that interact with ADAR1 and ADAR2 proteins or one of their first neighbors (Figure 3a) . Considering top associated genes with FDR < 0.01 we found 285 out of 376 (76%) interactors. The observed fraction of ADARs-connected genes represents a significant enrichment compared to random groups (empirical p-value < 1e-06, Figure 3b ) and these genes are strongly enriched for RNA binding proteins (Figure 3c ). Significant genes also includes 9 genes with direct interactions with ADARs (Table 2) . We estimated the role of each node in this network looking at degree and betweenness values. Degree value account for the number of interaction involving a single node in the network, while betweenness is a measure of centrality based on shortest paths. Node with higher betweenness centrality would have a major role in the network, because more information will pass through that node. Among ADARs proteins, ADAR1 is the main target of network interactions (0.077 betweenness centrality, 72 degree values) compared to ADAR2 (0.018 betweenness centrality, 29 degree). Among associated genes with a direct interaction with ADARs, ELAVL1, RPA1 and IFI16 act as relevant hub nodes, with betweenness centrality values of 0.137, 0.028, 0.020, respectively (Figure 3d ). Detailed network-based statistics are reported in Additional file 4, together with adjusted P value for association with CES total editing rate.
Biological factors possibly influencing editing levels
In order to identify possible biological factors influencing editing levels, we studied the correlation of the 28 biological / pharmacological variables described in Additional file 1, table S2 with CES total editing rate and with the ADAR expression level. Overall, 5 variables (age, current and maximum BMI, sex and blood pressure medications) revealed a significant correlation (Figure 4 , complete results in Additional File 1: Table S3 ). The same variables, with the exception of sex, resulted also significantly correlated with the expression level of ADAR. To better investigate the effect of biological / pharmacological variables and of ADAR expression and identify correlations between these variables and specific groups of CES, we performed principal component (PC) analysis of CES editing levels. Even if the variance explained by single component is generally low (PC1 ~ 0.025), our data revealed 24 factors with a significant correlation (p-value < 0.05) with one of the first 5 PCs ( Figure 5 and Additional file 1: Table S4 ).
Sex, age and BMI, were confirmed as major contributors to editing variability being associated to PC1 and 2 and influencing also lower components. Substance intake variables, including alcohol, smoke and drugs assumption, were clearly associated to PC3, even if few of the observed associations, namely alcohol intake, thyroid and cholesterol lowering medications, may be influenced by sex biased distribution (Additional file 1: Table S5 ). As expected from the analysis of genes influencing CES total editing rate, ADAR expression level resulted associated to the first 2 PCs, confirming its pivotal role in shaping editing levels variability. Correlation of editing levels for single sites with the first 5 PCs are reported in Additional file 5.
Identification of genetic var iants influencing CES total editing rate
We performed genome wide association analysis between genotyping data of 573,801 SNPs and CES total editing rate to identify SNPs associated to editing levels in human blood (Figure 6a ).
Based on GRASP database of known SNP-phenotype associations, the 100 SNPs with the lowest pvalues are involved in 44 human phenotypes with strongest impact on ADAR expression and AraC toxicity (Additional file 1: Table S6 ). Among these SNPs, 25 SNPs are known eQTLs regulating expression of 19 genes in blood tissue (Additional file 1: Table S7 ). These genes resulted to be nominally enriched for genes encoding for RNA-binding proteins involved in transcription regulation and response to cytokines (Additional file 1: Figure S6 ).
After variant clumping, our analysis identified a single significant locus on chromosome 7 (rs856554: p-value 1.86e-7, FDR 0.042), containing the lincRNA gene LOC730338 (ENSG00000233539) (Figure 6b and Table 3 ). The SNP rs856554 showed a significant effect on CES total editing rate and seems to influence ADAR expression, despite this effect do not reach statistical significance (Figure 6c ). Association results for single SNPs with nominal p-value < 0.05 and for loci after variants clumping are reported in Additional file 6.
Taken together, the 36 known ADAR eQTLs present in genotyping data explain 5.5% of CES total editing rate variability (p value 3.46e-4) and 5 of them resulted among the top 100 associated SNPs (Additional file 1: Table S8 ). The effect of the top associated ADAR eQTL (rs6699825) on ADAR expression and CES total editing rate is represented in Figure 6d .
Discussion
The process of A-to-I RNA editing has gained increasing attention in recent years, being implicated in multiple aspects of human physiology and, when dysregulated, in human diseases, such as neurological disorders and cancer [2, 9, 24] . Thanks to advances in next-generation sequencing technology, the prevalence and dynamic of "RNA editome" have been recently characterized across many tissues and developmental stages [18, 19, 21, 22] .
Overall, more than 2 million editing sites have been described so far, but most of them occur at very low level in inverted repeat ALU sequences and likely represent random editing with low impact on biological functions [32] . To focus only on those sites that are most likely biologically relevant in human blood, we first selected consistently edited sites (CES) across our dataset of about 450 RNASeq samples, resulting in a group of 2,079 sites with at least 5 % editing in at least 100 individuals.
As expected, the majority of these sites are located in inverted repeat ALU sequences [18, 19] that facilitate the formation of a RNA double stranded secondary structure with high affinity for ADAR editing enzymes. Interestingly, near 60% of detectable editing sites are located in the 3'UTRs, that are known preferred binding sites for miRNAs. This suggests a potential extensive role of editing process in modulating the miRNA mediated regulation of gene expression in blood. Indeed, RNA editing in the 3'UTRs might introduce nucleotide changes to miRNA target sites or stabilize RNA secondary structure reducing the accessibility for AGO2-miRNAs complex [33] [34] [35] .
We identified 22 editing sites located in coding sequences: 12 resulting in synonymous modifications and 10 inducing non-synonymous amino acid changes (re-coding sites). Among the latter, there were well studied re-coding sites, such as the S/G site of AZIN1 [8] , that mediates the binding to antizyme and cell cycle progression; the G/R site of BLCAP [36] , that is involved in the regulation of STAT3 signaling pathway; and the L/R site of NEIL1 [37] , that might modulate the DNA repair capability of the enzyme. Their editing levels range from high (75% of NEIL1) to medium-low (14% and 16% for BLCAP and AZIN1, respectively), indicating that both edited and unedited isoforms are needed for the proper function of the tissues. Interestingly, among the recoding sites, we also detected sites with an high editing level, such as two sites edited at 70% on the small subunit processome component (UTP14C). It is worth to notice that in blood cells several editing sites in 3'UTR and intronic regions reach an editing level of more than 90%. The high efficiency of editing indicates a strong ADARs binding, affecting transcripts stability or structure [38] , but the actual functional effect of these fully edited sites remain elusive. Overall, RNA editing process in human blood seems more pervasive than previously reported, prompting for further analyses to understand its biological effects also in healthy subjects.
Further, we investigated the association of genes expression with total editing rate of CES. ADAR (encoding ADAR1 enzyme) resulted as the top associated gene and its expression explained about 13% of observed variability, while ADARB1 (encoding ADAR2 enzyme) was not associated to global editing level even when ALU and non-ALU sites were considered separately. ADARB2
(encoding ADAR3 protein) is not expressed in blood cells, excluding that it could have a major negative effect on the editing levels in blood as observed for brain tissues [22] . Thus, ADAR1 emerges as the major contributor to editing process in blood, as already reported for human B cells and other tissues [22, 39] , while other ADAR enzymes seems to have only a limited effect. Overall, association analysis revealed 4,719 genes that might have a potential effect on the editing process, strongly enriched for genes involved in the immune system and interferon signaling. This supports the association between inflammatory processes and A-to-I editing, that seems mediated by ADAR expression modulation. Indeed, ADAR1 is present in two main isoforms, a constitutive p110 and an interferon inducible p150 form that is active under an inflammatory response [40] . Moreover, RNA editing, especially ADAR1 activity, are important to modulate innate immunity [41, 42] . Modification in the global editing level has been reported after inflammation in mouse and in vitro studies using several inflammatory mediators [43] .
When the effect of ADAR expression is removed from our analysis, new genes associated to global editing level emerged. These genes are mainly involved in RNA metabolism and ribonucleoprotein complex processing, confirming what recently found after a global analysis of GTEx data [22] and strengthening the role of RNA editing complex in the RNA processing [39] .
Associated genes after ADAR correction are strongly enriched for potential ADARs interactors, as revealed by network analysis using data from protein-protein interaction databases. Moreover, associated genes interacting with ADARs mainly encode for RNA binding proteins, as revealed by enrichment analysis, suggesting that they could be involved in RNA recognition or assembly of the editing complex. Network analysis showed that ADAR1 is the main target of these interactions, confirming its prevalent role in blood samples, compared to the other editing enzymes. We also identified 9 associated genes with direct interaction with ADARs. Among them, ELAVL1, RPA1 and IFI16 emerged as relevant hubs in the network, aggregating most of the interactions directed to ADARs proteins. The stabilizing RNA-binding protein human antigen R (HuR), encoded by ELAVL1, has been recently proposed as an ADAR1 interactor involved in the regulation of transcripts stability in human B cells [39] . It was unclear if this stabilizing effect is editing depended or not. However, ADAR1-mediated RNA editing of the 3'UTR of cathepsin S enables the recruitment of HuR to the 3' UTR, thereby controlling the cathepsin S mRNA stability and expression in endothelial cells and in human atherosclerotic vascular diseases [30] . The observed association between the global editing level and the ELAVL1 expression strengthens a general role of RNA editing in RNA stability through the modulation of expression of genes involved in RNA metabolism. RPA1 and IFI16 have never been involved in ADARs activity and represent new interesting partners that could expand the understanding of ADAR1 function and regulation. RPA1 gene encodes the largest subunit of the heterotrimeric Replication Protein A (RPA) complex, which binds to single-stranded DNA, forming a nucleoprotein complex that is involved in DNA replication, repair, recombination, telomere maintenance and response to DNA damage [44] .
ADAR1 presents Z-DNA binding domains, that are not present in the other editing enzymes [45] , helping to direct ADAR1 to active transcription sites and to interact with DNA. Thus, the interaction with RPA1 protein might broaden ADAR1 activity also in the field of DNA repair and maintenance. IFI16, interferon gamma inducible protein 16, encodes a member of the HIN-200 (hematopoietic interferon-inducible nuclear antigens with 200 amino acid repeats) cytokines family.
This protein interacts with p53 and retinoblastoma-1 and localizes to the nucleoplasm and nucleoli [46] , where also ADAR enzymes are present. Both IFI16 protein and ADAR1 were associated to response to viral DNA and regulation of immune and interferon signaling responses [46, 47] . Future studies will establish the actual functional meaning of these interactions and their role in RNA editing.
Recently, global editing level have been investigated across tissues and in different species [21, 22] and also correlated to the genetic background of human population [30] and to common disease variants [29] . However, the published studies lack a detailed characterization of samples that allows assessing the role of biological and environmental factors.
Relying on our dataset containing several demographic, biological and pharmacological variables, we also investigated the potential impact of these external factors on RNA editing process genomewide. Five variables showed significant correlations with CES total editing rate, namely blood pressure medications, sex, age and body mass index (BMI, current and max). Except for sex, their effect on editing levels seems mainly driven through modulation of ADAR expression. Correlation between age and editing was already reported during brain development both in rat [48] and in primates [49] and our data strengthens this correlation also outside the central nervous system. Moreover, it has been been previously suggested that in liver cancer, ALU editing is gender dependent, being lower in the tumor of female patients; however normal tissue do not showed this difference [50] . Here we showed that, at least in blood, gender is a main factor influencing RNA editing. Finally and for the first time, our study correlated CES editing levels with BMI and blood pressure medications, shedding light on new medical areas in which editing regulation may be involved.
A more detailed analysis using principal components of editing levels revealed twenty-four variables potentially influencing RNA editing for specific groups of sites in blood, even if the proportion of editing variability explained is low. Sex, age and BMI confirmed to have the strongest effect on RNA editing levels, being associated to the first principal component. PC1 and PC2 components are also strongly associated with ADAR expression, supporting that the observed effect of these biological factors could be due to modulation of ADAR. This data indicates that, when analyzing editing variations among different groups, such as in case / control studies, gender, age and other biological characteristics should be taken into account carefully to avoid biased results.
Interestingly, the third principal component is associated with variables related to drugs and substances intake, but only weakly with ADAR expression, indicating that drugs might modulate editing levels also through alternative mechanisms. A role of drugs, in particular antidepressants, have been reported for editing sites on specific neuronal transcripts [51] [52] [53] [54] . Our analysis suggests a broader impact of drugs, with several substances able to influence RNA editing process in blood.
Even if the contribution of single substances seems small, (PC3 explains ~0.7% of editing variability), substances intake overall may have a larger effect, as suggested by association of global intake variables ("all drugs" and "none treatments") with multiple principal components.
Finally, we analyzed genotyping data to identify SNPs associated to CES total editing rate. Known ADAR eQTLs resulted among the SNPs with the best p-values and, taken together, they explain about 5% of the observed variation in global editing. Our data confirmed that they actually influence expression of ADAR in blood and this explain also the observed effect on editing levels.
We found a single locus significantly associated with global editing level in blood, localized on lincRNAs appear to contribute to the control of gene expression and have a role in cell differentiation and maintenance of cell identity [55] . It has been recently reported in C. elegans that lncRNAs are extensively down-regulated in the absence of ADARs as a result of siRNA generation [56] . The authors suggests that ADARs can interfere with the generation of siRNAs by endogenous RNAi and promote lncRNA expression. LOC730339 expression cannot be measured in our dataset since it lack a poly-A tail; therefore, it is not possible to assess if the associated SNPs observed in the locus could act as eQTLs for this lincRNA. These SNPs seem to have only a marginal correlation with ADAR expression and the mechanism that link this locus and LOC730339 to editing process remain to be investigated.
According to GRASP, HaploReg and GTEx databases, the 100 SNPs with the best p-values also contain several SNPs reported in previous GWAS studies, as well as known eQTLs of genes coding for RNA binding proteins involved in transcription, supporting a co-regulation of RNA editing and transcription and a possible role of editing in several human phenotypes. Overall, this data indicates 13 that genetic variations, especially those associated to ADAR expression, can influence observed editing levels. The analysis of these SNPs should be taken into account when investigating editing levels in different human populations both in physiological and pathological conditions. Despite our RNA-seq dataset has only moderate coverage and thus may have limited power to investigate sites with very low editing levels, we assume that biologically relevant sites should be edited at detectable level consistently across samples [32] and thus our dataset is able to provide a detailed picture of the distribution and regulation of the most relevant editing events. Figure S7 ). Only the 14,961 genes covered with at least 10 reads in at least 100 subjects were considered in the present study for association with editing levels.
Conclusion
A detailed phenotypic description including demographic, pharmacological and biological variables is also included for each subject. Among them, we considered only those relevant in at least 30 subjects and not related to MDD clinical evaluation or socio-economic variables. The 28 variables considered in this study are reported in Additional file 1: Table S2 . Moreover, each experiment is annotated with a rich set of technical variables, representing quality metrics of RNA sequencing and characteristics of the blood sample. Normalized gene expression data is given as residuals of ridge regression of log-transformed read counts with 35 technical variables, to remove the effect of experimental biases (see the original paper [31] ).
Assessment of editing levels and selection of consistently edit ed sites
The original aligned reads were de-duplicated using Picard and the editing levels were then determined genome-wide from BAM files using REDITools v.1.0.4 [57] with the following parameters: -t25 -m20 -c10 -q25 -O5 -l -V0.05 -n0.05. Only sites with a minimum coverage of 10 reads were considered, otherwise their editing level was considered as missing.
To reduce the chance of measuring false-positive editing sites, we selected only sites that met the following criteria: i) sites reported within RefSeq genes by RADAR database [27] and never seen as Single Nucleotide Variants in the human population according to 1000G phase3 and ExAC v.0.3.1;
ii) sites occurring in regions were incorrect alignments could have generated artifacts in editing detection were filtered out: known pseudogenes from GENCODE v25; segmental duplication with ≥ 99% identity; single exon genes, that are often retrotransposed genes with high similarity to the corresponding parent gene.
The filtered dataset resulted in 709,184 sites, representing > 75% RADAR editing sites occurring in blood expressed genes. Finally, to provide a picture of most biologically relevant editing events in blood, we decided to focus only on sites with detectable editing levels (at least 5%) in at least 100 subjects (~20% of total individuals) for subsequent quantitative analysis, resulting in a final dataset of 2,079 sites (consistently edited sites, CES).
Comparison with REDIPortal dataset
We compared editing levels detected in CES from blood samples with similar data obtained from REDI Portal [26] . Editing levels were retrieved directly from REDIPortal database, containing RNA editing values calculated from 55 body sites of 150 healthy individuals from GTEx project. Mean editing levels of our 2,079 CES were compared with corresponding data reported for blood tissue in REDI portal. To assess concordance between the two datasets, we calculated concordance correlation coefficient between mean editing values detected in our data and reported in REDIPortal blood tissue for overlapping sites.
Correlation between editing levels across sites
Using Spearman correlation test, we analyzed correlation of editing levels across the 2,079 CES.
Each site was analyzed against all other sites for a total of 4,322,241 tests. FDR correction modified as in [58] was used to account for multiple tests with related variables. Corrplot R package v.0.84 was used to analyze correlation matrices and generate correlation plots.
Association between CES total editing rate and gene expression
To investigate which genes could influence the editing process, we used robust linear regression (robust v.0.4 R package) to assess the association between gene expression levels and the CES total editing rate in each subject. CES total editing rate for each subject was calculated as in Equation 1. The sum of number of G-containing reads (G i ) observed at all CES (m), divided by the sum of total reads observed (C i ) at all CES.
CES total editing rate was determined also for Alu sites and non-Alu sites, separately. To choose the set of phenotypic, biological and pharmacological variables to include as covariates in regression analyses, a stepwise model selection by AIC was performed (using stepAIC from MASS R package v.7.3-5). The 6 included variables are indicated in Additional file 1: Table S1 . Moreover, since there was a correlation between the variance observed at each editing site and its sequencing coverage for sites with coverage below ~ 40 X (Additional file 1: Figure S8 ), the log2 of reads count was also included as covariate in the analysis. The strength of the association was determined by ANOVA test comparing the null ('background') model that includes only the set of covariates with the full model (covariates plus normalized expression levels). FDR was used to correct for multiple tests.
Subsequently, association analyses were repeated including ADAR expression as additional covariate, to remove the effect of ADAR expression.
Gene set enrichment analysis and gene network analysis
The impact on biological functions and cellular pathways of genes found associated with CES total editing rate was investigated using hypergeometric test. We tested the over-representation of pathways among the subset of significant genes at 5% FDR level compared to all expressed genes. 
I dentification of biological factors correlated with editing levels
To investigate which biological and pharmacological variables could influence editing levels in blood, we studied associations between the 28 biological / pharmacological variables described in Additional file 1: Table S2 and CES total editing rate across subjects. For the 5 variables resulting in significant associations, we also analyzed their correlation with ADAR gene expression levels. To further investigate the effect of biological and pharmacological variables on editing levels in blood, we studied their correlation with the Principal Components of editing levels (PCs). To compute PCs, the missing values of the sites were first imputed using a nonparametric imputation method based on random forest (missForest R package v.1.4 [63] ). The PCs were then determined on the complete data using the prcomp R package. To identify the number of PCs to account for, we evaluated the percentage of explained variance by the top 30 PCs, and identified the 5 th component as the point at which the explained variance plateaus.
In both analyses, Kruskal-Wallis test, Mann-Whitney-Wilcoxon test and Pearson's product-moment correlation test were used to assess association for categorical, binary and continuous variables, respectively. To identify which editing sites were most correlated with each PC, we analyzed the loadings, that could be interpreted as correlation coefficient between the original variables and components. Moreover, given a high number of sites and low loading values, to deepen the role of each site in the computation of the PCs, we performed the Pearson correlation test. We considered a "moderate" correlation when its absolute value was between 0.3 and 0.5 and the test passed the Bonferroni threshold, while a "weak" correlation was considered when the correlation absolute values ranged between 0 and 0.3 and the respective p-values were significant for Bonferroni correction.
Association study for SNPs and global editing levels
To identify SNPs associated to global editing level, we analyzed genotyping data and global editing levels in the 459 human blood samples. Starting from genotypes provided in the original dataset [31] , we filtered raw data removing SNPs strongly deviating from Hardy-Weinberg equilibrium (fisher test p-value < 1e-4) and with a minor allele frequency below 0.10, to ensure that the least represented genotype accounts for at least 5 individuals. The final dataset contained 573,801 SNPs.
We used plink v.1.9 linear association analysis with additive model, including the same 7 covariates used for analysis of gene expression (see above, Additional file 1: Table S1 ). FDR was used to correct for multiple tests. After association analysis, we used GCTA [64] to evaluate the impact of ADAR known eQTLs on observed global editing levels, using the same set of covariates included for the plink association analysis. This analysis was performed including 36 known ADAR eQTLs present in our genotyping data. The top 100 associated SNPs were overlapped with GRASP 2.0 [65] database, to assess their role in human phenotypes and diseases. We then evaluated genes potentially regulated by the top 100 SNPs based on known blood eQTLs from HaploReg 4.1 [66] and GTEx [67] . Enrichment analysis was conducted for potentially regulated genes on GO:BP, GO:MF, GO:CC and REACTOME pathways using hypergeometric test. Background gene group was obtained as all genes with a known eQTL among all the 573,801 tested SNPs. To identify 19 significant loci associated to global editing level, we performed variant clumping based on the association results, using plink with 1Mb window and 0.5 R2 thresholds. In this way all SNPs in 1Mb window and with R2 ≥ 0.5 are grouped together around the index SNP, that is the SNP with the lower association p-value. Authors' contributions 21 EG, AB conceived and designed the analysis. EG, CS performed bioinformatic and statistical analysis. MG acquired the data. MG and CM provided intellectual input and conceptual advice and revised the paper. EG, AB, CS wrote the paper. All authors read and approved the final manuscript. 
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